SCHEMBL20012906

SCHEMBL20012906

Ic1cnc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)nc1-n1ccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 3/20 0.46
▸ AURKA O14965 1/20 0.46
▸ FGFR1 P11362 6/20 0.46
▸ JAK3 P52333 6/20 0.45
▸ JAK2 O60674 5/20 0.45
▸ JAK1 P23458 5/20 0.45
▸ FGFR4 P22455 2/20 0.45
▸ KDR P35968 2/20 0.45
▸ SYK P43405 2/20 0.44
▸ CD38 P28907 1/20 0.43
▸ FGFR2 P21802 1/20 0.43
▸ FGFR3 P22607 1/20 0.43
▸ CDK1 P06493 2/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCND1 P24385 2/20 0.43
▸ CCNE1 P24864 2/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ CCNB2 O95067 1/20 0.43
▸ CCNE2 O96020 1/20 0.43
▸ CCNA2 P20248 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20012903 0.90 SYK (0.53) CDK4AURKAJAK3JAK2JAK1
SCHEMBL20012909 0.90 PDGFRB (0.50) CDK4AURKAFGFR1JAK2FGFR4
SCHEMBL20012991 0.89 FGFR1 (0.53) CDK4AURKAFGFR1JAK3JAK2
SCHEMBL20012920 0.87 TTK (0.57) FGFR1PTK2IGF1R
SCHEMBL20012936 0.83 WEE1 (0.47) CDK4JAK3JAK2JAK1FGFR4
SCHEMBL20012904 0.81 CDK4 (0.54) CDK4AURKAFGFR1JAK2FGFR4
SCHEMBL20012902 0.78 INSR (0.60) IGF1R
SCHEMBL20012919 0.77 ALK (0.58) CDK4AURKAJAK3JAK2JAK1
SCHEMBL20012945 0.77 INSR (0.62) AURKAFGFR1JAK2FGFR4KDR
SCHEMBL20012932 0.75 FGFR3 (0.58) FGFR1FGFR4KDRFGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018056621-A1 NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2018-03-29 — — WO disclosed
Send feedback